Neodymium-yag laser vitreolysis in sickle cell retinopathy

Nick F. Hrisomalos, Lee M. Jampol, Brendan J. Moriarty, Graham Serjeant, Robert Acheson, Morton F Goldberg

Research output: Contribution to journalArticle

Abstract

Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.

Original languageEnglish (US)
Pages (from-to)1087-1091
Number of pages5
JournalArchives of Ophthalmology
Volume105
Issue number8
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Neodymium
Lasers
Solid-State Lasers
Choroid Hemorrhage
Vitreoretinal Surgery
Retinal Vein
Retinal Pigment Epithelium
Traction
Treatment Failure
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hrisomalos, N. F., Jampol, L. M., Moriarty, B. J., Serjeant, G., Acheson, R., & Goldberg, M. F. (1987). Neodymium-yag laser vitreolysis in sickle cell retinopathy. Archives of Ophthalmology, 105(8), 1087-1091. https://doi.org/10.1001/archopht.1987.01060080089034

Neodymium-yag laser vitreolysis in sickle cell retinopathy. / Hrisomalos, Nick F.; Jampol, Lee M.; Moriarty, Brendan J.; Serjeant, Graham; Acheson, Robert; Goldberg, Morton F.

In: Archives of Ophthalmology, Vol. 105, No. 8, 1987, p. 1087-1091.

Research output: Contribution to journalArticle

Hrisomalos, NF, Jampol, LM, Moriarty, BJ, Serjeant, G, Acheson, R & Goldberg, MF 1987, 'Neodymium-yag laser vitreolysis in sickle cell retinopathy', Archives of Ophthalmology, vol. 105, no. 8, pp. 1087-1091. https://doi.org/10.1001/archopht.1987.01060080089034
Hrisomalos, Nick F. ; Jampol, Lee M. ; Moriarty, Brendan J. ; Serjeant, Graham ; Acheson, Robert ; Goldberg, Morton F. / Neodymium-yag laser vitreolysis in sickle cell retinopathy. In: Archives of Ophthalmology. 1987 ; Vol. 105, No. 8. pp. 1087-1091.
@article{5e2b10c324e248689f4aa384022040ce,
title = "Neodymium-yag laser vitreolysis in sickle cell retinopathy",
abstract = "Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.",
author = "Hrisomalos, {Nick F.} and Jampol, {Lee M.} and Moriarty, {Brendan J.} and Graham Serjeant and Robert Acheson and Goldberg, {Morton F}",
year = "1987",
doi = "10.1001/archopht.1987.01060080089034",
language = "English (US)",
volume = "105",
pages = "1087--1091",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Neodymium-yag laser vitreolysis in sickle cell retinopathy

AU - Hrisomalos, Nick F.

AU - Jampol, Lee M.

AU - Moriarty, Brendan J.

AU - Serjeant, Graham

AU - Acheson, Robert

AU - Goldberg, Morton F

PY - 1987

Y1 - 1987

N2 - Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.

AB - Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.

UR - http://www.scopus.com/inward/record.url?scp=0023256755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023256755&partnerID=8YFLogxK

U2 - 10.1001/archopht.1987.01060080089034

DO - 10.1001/archopht.1987.01060080089034

M3 - Article

C2 - 3632418

AN - SCOPUS:0023256755

VL - 105

SP - 1087

EP - 1091

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 8

ER -